Radiofrequency ablation of inferior turbinates for rhinitis medicamentosa: a systematic review and case series.

Authors

Nurhan Abbud, George Ninkovic-Hall, Sandeep G Mistry

Published in

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

Rhinitis medicamentosa (RM) affects up to 9% of patients seen in rhinology clinics and remains difficult to manage once topical decongestant dependence develops. Conservative measures often fail. Radiofrequency ablation (RFA) of the inferior turbinates offers a minimally invasive alternative that targets mucosal hypertrophy and may support withdrawal.
A systematic review was conducted in accordance with PRISMA 2020 and prospectively registered with PROSPERO (CRD420251137740). Studies reporting outcomes of inferior turbinate RFA for RM were identified from MEDLINE, Embase, Scopus and Cochrane databases. Primary outcomes were decongestant cessation and change in validated symptom scores. In addition, a retrospective institutional case series of 25 consecutive patients treated with RFA was analysed.
Four studies met inclusion criteria (66 patients). All reported symptomatic improvement, with decongestant cessation in up to 100% of cases and minimal complications. In our series, 18 of 21 (85.7%) patients with follow-up discontinued decongestants, and mean SNOT-22 improved from 54.5 ± 19.0 to 35.0 ± 24.2 (p = 0.0008). No major complications occurred.
This is the first combined systematic review and case series evaluating RFA for RM. RFA is a safe, outpatient procedure associated with high rates of decongestant cessation and clinically meaningful symptom improvement. Its low complication profile supports its role as a low-risk outpatient option for selected patients with refractory RM in secondary care.

PMID:
42507205
Bibliographic data and abstract were imported from PubMed on 27 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.